Home > Marketing > Nitroglycerin Expansion to be Persistent During 2020-2024

Nitroglycerin Expansion to be Persistent During 2020-2024

Added: (Tue Mar 03 2020)

Pressbox (Press Release) - Global Nitroglycerin Market Overview:

This Nitroglycerin market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Nitroglycerin market.

Nitroglycerin is a colorless and oily liquid with high density. It is generally manufactured by reacting nitrating glycerin with nitric acid in appropriate conditions. It is used for two major purposes: one is as an explosive and other is as a medicine. The growing API industry is also responsible for increasing the demand for API raw materials.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/247006 .

The report has been accumulated through meticulous primary and secondary research, which encompasses interviews, inspections, and observations of experienced analysts, as well as proven paid sources, news articles, annual reports, trade journals, and company body databases. The study also presents a qualitative and quantitative evaluation by analyzing the data collected from industry professionals and market participants across crucial factors in the industry's value chain. These segments are studied in detail for the market estimates and forecasts at regional and country level. This analysis is useful in understanding the growth areas and probable opportunities of the market.

Top Major Key Players in the Global Nitroglycerin Market:

Nitroglycerin Devices Market is moderately competitive and consists of several major players. In terms of market share, some of the major players currently dominate the market. The end-users demand is driven by safety and regulatory needs and the companies operating in the market are leveraging on strategic collaborative initiatives, to offer specialized solutions, to increase their market share and increase their profitability. The companies operating in the market are also into mergers and acquisitions of start-ups that help in improving the served market portfolio on Nitroglycerin Devices to strengthen their product capabilities. Among the prominent players involved in the Nitroglycerin technology market, companies such as :

Pfizer

Mylan N.V.

Espero BioPharma

Sun Pharmaceutical Industries

Glenmark Pharmaceuticals

Troikaa

Square Pharmaceuticals

Segmentations :

Product Type Segmentation

Tablets

Onitments

Patches

Others

Industry Segmentation

Angina Pectoris Treatment

Prostate Cancer Treatment

Regional Analysis :

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Columbia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Global Industry News:

Glenmark Pharmaceuticals and Hikma enter into an Exclusive Licensing Agreement for commercializing Ryaltris Seasonal Allergic Rhinitis Nasal Spray in the US Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltris by the US FDA, while Hikma will be responsible for the commercialization of Ryaltris in the US Glenmark will receive an upfront payment, regulatory approval and commercial milestone payments as well as royalties from Hikma for Ryaltris.

Feb 27, 2020: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Hikma Pharmaceuticals PLC (Hikma) for commercializing its novel nasal spray Ryaltris™ in the US.

The agreement with Hikma is Glenmark’s fourth regional licensing deal for Ryaltris™. Glenmark has

already signed licensing deals for commercializing Ryaltris in China, Australia, New Zealand and SouthKorea. Ryaltris™ [olopatadine hydrochloride (665 mcg) and mometasone furoate (25 mcg)], developed by Glenmark, is a novel fixed-dose combination nasal spray of an anti-histamine and a steroid, indicated for treatment of symptoms associated with seasonal allergic rhinitis (SAR) in patients over 12 years of age.

Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltri by the US Food and Drug Administration (FDA). Hikma will be responsible for the commercialization of Ryaltris™ in the US following approval. Hikma would also have the ability to produce the product utilizing its nasal manufacturing capabilities in Columbus, Ohio. Glenmark will receive an upfront payment, regulatory approval and commercial milestone payments as well as royalties from Hikma for Ryaltris

Purchase this report online with 125 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Nitroglycerin Report 2020” @ https://www.businessindustryreports.com/buy-now/247006/single .

This research study inspects the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-complexity information regarding the development, trends, and industry policies and guidelines implemented in each of the geographical regions. Further, the overall directing framework of the market has been thoroughly covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/247006 .

Major Points in Table of Contents:

Section 1 Nitroglycerin Product Definition

Section 2 Global Nitroglycerin Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Nitroglycerin Shipments

2.2 Global Manufacturer Nitroglycerin Business Revenue

2.3 Global Nitroglycerin Market Overview

Section 3 Manufacturer Nitroglycerin Business Introduction

3.1 Pfizer Nitroglycerin Business Introduction

3.1.1 Pfizer Nitroglycerin Shipments, Price, Revenue and Gross profit 2014-2019

3.1.2 Pfizer Nitroglycerin Business Distribution by Region

3.1.3 Pfizer Interview Record

3.1.4 Pfizer Nitroglycerin Business Profile

3.1.5 Pfizer Nitroglycerin Product Specification

3.2 Mylan N.V. Nitroglycerin Business Introduction

3.2.1 Mylan N.V. Nitroglycerin Shipments, Price, Revenue and Gross profit 2014-2019

3.2.2 Mylan N.V. Nitroglycerin Business Distribution by Region

3.2.3 Interview Record

3.2.4 Mylan N.V. Nitroglycerin Business Overview

3.2.5 Mylan N.V. Nitroglycerin Product Specification

3.3 Espero BioPharma Nitroglycerin Business Introduction

3.3.1 Espero BioPharma Nitroglycerin Shipments, Price, Revenue and Gross profit 2014-2019

3.3.2 Espero BioPharma Nitroglycerin Business Distribution by Region

3.3.3 Interview Record

3.3.4 Espero BioPharma Nitroglycerin Business Overview

3.3.5 Espero BioPharma Nitroglycerin Product Specification

3.4 Sun Pharmaceutical Industries Nitroglycerin Business Introduction

3.5 Glenmark Pharmaceuticals Nitroglycerin Business Introduction

3.6 Troikaa Nitroglycerin Business Introduction

…About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940



Submitted by:8308356129
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.com together with the url of the release.